World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
112
Citations
61502
World Ranking
5066
National Ranking
2742

Overview

Dean F. Bajorin is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research primarily resides within the field of Medicine, with significant contributions to several subfields including Surgery, Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, and Epidemiology.

Their work encompasses topics centered on cancer research and treatment, especially related to bladder and urothelial cancers, urinary and genital oncology studies, and cancer immunotherapy and biomarkers. Additional topics include epigenetics and DNA methylation, esophageal cancer research and treatment, fibroblast growth factor research, and renal cell carcinoma treatment.

Dean F. Bajorin has published extensively in several scientific journals. The most frequent venues for their publications include:

  • Journal of Clinical Oncology
  • The Journal of Urology
  • European Urology
  • Clinical Cancer Research
  • Annals of Oncology

Notable recent papers authored or co-authored by Bajorin include:

  • Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma (2021), New England Journal of Medicine
  • Cancer therapy shapes the fitness landscape of clonal hematopoiesis (2020), Nature Genetics
  • Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study (2021), The Lancet Oncology
  • Long-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelial Cancer (2020), Journal of Clinical Oncology
  • LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade (2021), Science Translational Medicine

Frequent collaborators in Bajorin's research include Jonathan E. Rosenberg, Samuel A. Funt, Hikmat Al-Ahmadie, Bernard H. Bochner, and Gopa Iyer. These co-authors have multiple joint publications, reflecting ongoing research partnerships.

Best Publications

  • Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: A single-arm, multicentre, phase 2 trial

    Jonathan E Rosenberg;Jean Hoffman-Censits;Tom Powles;Michiel S van der Heijden

  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types.

    Robert M Samstein;Chung-Han Lee;Chung-Han Lee;Alexander N Shoushtari;Alexander N Shoushtari;Matthew D Hellmann;Matthew D Hellmann

  • Comprehensive molecular characterization of urothelial bladder carcinoma

    John N Weinstein;Rehan Akbani;Bradley McIntosh Broom;Wenyi Wang

  • Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

    Joaquim Bellmunt;Ronald De Wit;David J. Vaughn;Yves Fradet

  • Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.

    Arjun V. Balar;Matthew D. Galsky;Jonathan E. Rosenberg;Thomas Powles

  • International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers

    GM Mead;SP Stenning;P Cook;SD Fossa

  • First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study

    Arjun V Balar;Daniel Castellano;Peter H O'Donnell;Petros Grivas

  • Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer.

    Harry W. Herr;Bernard H. Bochner;Guido Dalbagni;S. Machele Donat

  • Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy

    Dean F. Bajorin;Paul M. Dodd;Madhu Mazumdar;Melissa Fazzari

  • Genome Sequencing Identifies a Basis for Everolimus Sensitivity

    Gopa Iyer;Gopa Iyer;Aphrothiti J. Hanrahan;Matthew Ivan Milowsky;Matthew Ivan Milowsky;Hikmat Al-Ahmadie

  • Treatment of Patients With Metastatic Urothelial Cancer “Unfit” for Cisplatin-Based Chemotherapy

    Matthew D. Galsky;Noah M. Hahn;Jonathan Rosenberg;Guru Sonpavde

  • Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.

    Dean F Bajorin;J Alfred Witjes;Jürgen E Gschwend;Michael Schenker

  • CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

    Padmanee Sharma;Yu Shen;Sijin Wen;Sachiko Yamada

  • Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma

    Eliezer M Van Allen;Kent W. Mouw;Philip Kim;Gopa Iyer

  • Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer.

    Bernard H. Bochner;Guido Dalbagni;Michael W. Kattan;Paul Fearn

  • Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer

    Alicia Latham;Preethi Srinivasan;Yelena Kemel;Jinru Shia

  • Cancer therapy shapes the fitness landscape of clonal hematopoiesis

    Kelly L. Bolton;Ryan N. Ptashkin;Teng Gao;Lior Braunstein

  • Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tumors

    G. Varuni Kondagunta;Jennifer Bacik;Alessia Donadio;Dean Bajorin

  • Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers

    Min Yuen Teo;Kenneth Seier;Irina Ostrovnaya;Ashley M. Regazzi

  • Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing

    Diana Mandelker;Liying Zhang;Yelena Kemel;Yelena Kemel;Zsofia K. Stadler;Zsofia K. Stadler

Frequent Co-Authors

Jonathan E. Rosenberg
Jonathan E. Rosenberg Memorial Sloan Kettering Cancer Center
Robert J. Motzer
Robert J. Motzer Memorial Sloan Kettering Cancer Center
David B. Solit
David B. Solit Memorial Sloan Kettering Cancer Center
Bernard H. Bochner
Bernard H. Bochner Memorial Sloan Kettering Cancer Center
Hikmat Al-Ahmadie
Hikmat Al-Ahmadie Memorial Sloan Kettering Cancer Center
George J. Bosl
George J. Bosl Memorial Sloan Kettering Cancer Center
Guido Dalbagni
Guido Dalbagni Memorial Sloan Kettering Cancer Center
Michael F. Berger
Michael F. Berger Memorial Sloan Kettering Cancer Center
Joaquim Bellmunt
Joaquim Bellmunt Beth Israel Deaconess Medical Center
Harry W. Herr
Harry W. Herr Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternatives to the traditional path of studying Medicine in the USA can open up a variety of rewarding healthcare careers. Many students are now considering flexible, online programs that provide both convenience and cost savings. For those interested in mental health practice, the fastest post master's pmhnp programs offer a quick route to becoming a psychiatric mental health nurse practitioner, addressing a growing need across the country.

If healthcare leadership and administration are your goals, a health care administration degree online can be a stepping stone to management positions in hospitals and clinics. Cost is always a concern, but there are cheapest mha programs online that make earning a master’s in healthcare administration more accessible for many students.

For those seeking the highest level of nursing practice, finding the cheapest dnp is crucial in order to pursue advanced opportunities without excessive debt. These online degree pathways allow students to work while studying and to enter in-demand healthcare careers faster and more affordably.

Best Scientists Citing Dean F. Bajorin

Trending Scientists

Recently Published Articles